The rabies antibody titration test shall:
be carried out without undue delay after sample collection on a sample collected by an official veterinarian or an authorised veterinarian as defined in Article 2(1) of Delegated Regulation (EU) 2026/131 at least 30 days after the date of the primary vaccination, or within a current valid vaccination series, and not less than 90 days before the date of issue of the animal health certificate accompanying the consignment of animals to the Union;
measure a titre of neutralising antibody to rabies virus equal to or greater than 0,5 IU/ml and using a method prescribed in the relevant part of the chapter concerning rabies in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health (WOAH);
be performed in one of the following:
an official laboratory designated in accordance with Article 37 of Regulation (EU) 2017/625 for the performance of the rabies antibody titration test and for which the competent authority has provided to the Commission its name and contact details; or
a laboratory in a third country or territory listed in Annex VIII to Implementing Regulation (EU) 2021/404 designated by the competent authority of the third country as meeting the requirements laid down in Article 37(4) and (5) of Regulation (EU) 2017/625 for the performance of the rabies antibody titration test and for which the competent authority has provided to the Commission its name and contact details;
be certified by an official report from the designated laboratory referred to in point (c) as regards the results of the rabies antibody titration test.
A report issued from 1 January 2028 shall bear a security feature in the format of a code to permit verification of its authenticity on the dedicated internet-based pages of the designated laboratory and be attached to the animal health certificate referred to in point (a);
not have to be renewed on an animal which, following the antibody rabies titration test with satisfactory results, has been revaccinated against rabies within the period of validity of the primary vaccination referred to in point (a) and all subsequent valid vaccinations in the series.
Prior to entering a Member State or zone thereof with disease-free status for Echinococcus multilocularis, dogs shall be treated against infestation with Echinococcus multilocularis, as follows:
the treatment shall consist of an approved veterinary medicinal product which contains the appropriate dose of praziquantel or other pharmacologically active substances, which alone or in combination, have proven to reduce the burden of mature and immature intestinal forms of Echinococcus multilocularis in dogs at least as effectively as praziquantel;
the product shall be administered by a veterinarian within a period commencing not more than 120 hours and ending not less than 24 hours prior to the time of entering that Member State or zone.